指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

预测泌尿外科实践的未来:国际与欧洲协会关于COVID-19大流行期间优先手术建议的综合综述

Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic.
指南 / 共识 · Eur Urol Focus · 2020-05-31
一句话结论综述13个泌尿协会建议:门诊前列腺活检与良性病择期手术、住院低危前列腺癌与肾癌择期手术、非梗阻性结石及良性前列腺增生手术将最大程度影响未来泌尿外科工作量。

该综述检索2020年4月8日至18日间13个泌尿协会(4个国际、9个国家)官网发布的COVID-19期间优先分级建议,按疾病、优先级和患者场景分层分析。门诊场景中,前列腺活检和良性病择期手术对未来工作量负担影响最大;住院场景中,低危前列腺癌和肾癌择期手术、非梗阻性结石病及良性前列腺增生手术贡献最大。各协会对大多数泌尿手术优先级高度一致,但在特定癌症手术(如高危膀胱癌根治性膀胱切除术、较大器官局限肾肿块肾切除术)上存在差异。部分协会建议微创手术特殊防护,另一些强调远程医疗优化资源。作者认为泌尿外科医生应利用这一应急期重塑未来角色。

要点

  • 门诊场景中,对未来泌尿外科医生工作量负担影响最大的操作是前列腺活检和良性病择期手术。
  • 住院场景中,对未来工作量负担贡献最大的择期手术包括低危前列腺癌和肾癌手术、非梗阻性结石病及良性前列腺增生手术。
  • 13个泌尿协会对大多数泌尿操作(门诊、泌尿急诊及多数住院肿瘤与非肿瘤手术)的优先级高度一致。
  • 特定癌症手术存在协会间差异:高危膀胱癌根治性膀胱切除术和较大器官局限肾肿块肾切除术的优先级标准或医疗环境不同。
  • 部分协会建议微创手术时采取特殊防护措施,另一些协会强调远程医疗在当前和未来场景中优化资源的作用。

适用人群与场景

  • COVID-19大流行期间泌尿外科门诊和住院患者,涵盖肿瘤与非肿瘤疾病。
  • 门诊场景包括前列腺活检和良性病择期手术;住院场景包括低危前列腺癌和肾癌择期手术、非梗阻性结石病及良性前列腺增生手术。

处置流程与药物剂量

  • 部分泌尿协会建议微创手术时采取特殊防护措施。
  • 部分泌尿协会强调远程医疗在当前和未来场景中优化资源的作用。

研究设计与关键结果

  • 综述分析了13个泌尿协会的建议,其中4个国际协会(美国泌尿协会、美洲泌尿联合会、欧洲泌尿协会、澳大利亚和新西兰泌尿学会)和9个国家协会(来自比利时、法国、德国、意大利、波兰、葡萄牙、荷兰和英国)。
  • 门诊场景中,对未来泌尿外科医生工作量负担影响最大的操作是前列腺活检和良性病择期手术。
  • 住院场景中,对未来工作量负担贡献最大的择期手术为低危前列腺癌和肾癌手术、非梗阻性结石病及良性前列腺增生手术。
  • 各协会对大多数泌尿操作(包括门诊、泌尿急诊及多数住院肿瘤与非肿瘤手术)的优先级高度一致。
  • 特定癌症手术存在协会间差异:高危膀胱癌根治性膀胱切除术和较大器官局限肾肿块肾切除术,可能因优先级标准或医疗环境不同。

证据类型、等级与局限

  • 证据类型:综述,检索2020年4月8日至18日间泌尿协会官网发布的文件、出版物或立场文件。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,预期的变化将在泌尿外科医生总体工作量、内部后勤、手术患者流入和等待名单方面给全球泌尿外科单元带来显著压力。
  • 作者认为,泌尿外科医生应努力利用这一应急期来重塑其未来角色。

指南或共识出处

  • 欧洲泌尿协会、美国泌尿协会、美洲泌尿联合会、澳大利亚和新西兰泌尿学会及比利时、法国、德国、意大利、波兰、葡萄牙、荷兰和英国国家泌尿协会在COVID-19大流行期间发布的优先分级建议文件(检索时间2020年4月8日至18日)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

CONTEXT: The unprecedented health care scenario caused by the coronavirus disease 2019 (COVID-19) pandemic has revolutionized urology practice worldwide.

OBJECTIVE: To review the recommendations by the international and European national urological associations/societies (UASs) on prioritization strategies for both oncological and nononcological procedures released during the current emergency scenario.

EVIDENCE ACQUISITION: Each UAS official website was searched between April 8 and 18, 2020, to retrieve any document, publication, or position paper on prioritization strategies regarding both diagnostic and therapeutic urological procedures, and any recommendations on the use of telemedicine and minimally invasive surgery. We collected detailed information on all urological procedures, stratified by disease, priority (higher vs lower), and patient setting (outpatient vs inpatient). Then, we critically discussed the implications of such recommendations for urology practice in both the forthcoming "adaptive" and the future "chronic" phase of the COVID-19 pandemic.

EVIDENCE SYNTHESIS: Overall, we analyzed the recommendations from 13 UASs, of which four were international (American Urological Association, Confederation Americana de Urologia, European Association of Urology, and Urological Society of Australia and New Zealand) and nine national (from Belgium, France, Germany, Italy, Poland, Portugal, The Netherlands, and the UK). In the outpatient setting, the procedures that are likely to impact the future burden of urologists' workload most are prostate biopsies and elective procedures for benign conditions. In the inpatient setting, the most relevant contributors to this burden are represented by elective surgeries for lower-risk prostate and renal cancers, nonobstructing stone disease, and benign prostatic hyperplasia. Finally, some UASs recommended special precautions to perform minimally invasive surgery, while others outlined the potential role of telemedicine to optimize resources in the current and future scenarios.

CONCLUSIONS: The expected changes will put significant strain on urological units worldwide regarding the overall workload of urologists, internal logistics, inflow of surgical patients, and waiting lists. In light of these predictions, urologists should strive to leverage this emergency period to reshape their role in the future.

PATIENT SUMMARY: Overall, there was a large consensus among different urological associations/societies regarding the prioritization of most urological procedures, including those in the outpatient setting, urological emergencies, and many inpatient surgeries for both oncological and nononcological conditions. On the contrary, some differences were found regarding specific cancer surgeries (ie, radical cystectomy for higher-risk bladder cancer and nephrectomy for larger organ-confined renal masses), potentially due to different prioritization criteria and/or health care contexts. In the future, the outpatient procedures that are likely to impact the burden of urologists' workload most are prostate biopsies and elective procedures for benign conditions. In the inpatient setting, the most relevant contributors to this burden are represented by elective surgeries for lower-risk prostate and renal cancers, nonobstructing stone disease, and benign prostatic hyperplasia.

来源:Eur Urol Focus,查看原文。版权归原作者所有。

参考来源

  1. Amparore D, Campi R, Checcucci E, et al. Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic. Eur Urol Focus. 2020. PMID: 32553544. doi:10.1016/j.euf.2020.05.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。